These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12878436)

  • 1. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
    van Horssen J; Wesseling P; van den Heuvel LP; de Waal RM; Verbeek MM
    Lancet Neurol; 2003 Aug; 2(8):482-92. PubMed ID: 12878436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
    Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
    Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
    Buée L; Ding W; Delacourte A; Fillit H
    Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
    Benditt EP
    Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
    van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and heparan sulfate proteoglycan.
    Fukuchi K; Hart M; Li L
    Front Biosci; 1998 Mar; 3():d327-37. PubMed ID: 9490646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
    Perlmutter LS; Chui HC; Saperia D; Athanikar J
    Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.
    van Horssen J; Wilhelmus MM; Heljasvaara R; Pihlajaniemi T; Wesseling P; de Waal RM; Verbeek MM
    Brain Pathol; 2002 Oct; 12(4):456-62. PubMed ID: 12408231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
    Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
    Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
    Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
    FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
    Ariga T; Miyatake T; Yu RK
    J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
    Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
    Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism.
    Ozsan McMillan I; Li JP; Wang L
    Am J Physiol Cell Physiol; 2023 Apr; 324(4):C893-C909. PubMed ID: 36878848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease.
    Lam V; Takechi R; Pallebage-Gamarallage MM; Galloway S; Mamo JC
    Neurosci Lett; 2011 Apr; 492(3):160-4. PubMed ID: 21310214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.